The U.S. Food and Drug Administration cleared a shortened version of a gene for a muscle protein to be used in 4- and 5-year-olds with muscular dystrophy.

The FDA OK'd the treatment only for children ages 4 and 5, based on study results showing the therapy helped produce a protein needed for muscle growth, which is missing in boys with the condition.

Olympic gold medalist and WWE Hall of Famer Kurt Angle meets fans, delivering lessons on experiences and mindset that made ...

First gene therapy for deadly form of muscular dystrophy gets FDA approval for young kids ... Updated: 3:28 AM CDT Jun 23, 2023 Editorial Standards ⓘ By MATTHEW PERRONE, AP Health Writer ...

First gene therapy for deadly form of muscular dystrophy gets FDA approval for young kids Share Updated: 3:28 AM CDT Jun 23, 2023 Infinite Scroll Enabled ...

The FDA OK'd the treatment only for children ages 4 and 5, based on study results showing the therapy helped produce a protein needed for muscle growth, which is missing in boys with the condition.